<VariationArchive VariationID="1365083" VariationName="NM_000528.4(MAN2B1):c.161_162del (p.Thr54fs)" VariationType="Deletion" Accession="VCV001365083" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-28" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1502127" VariationID="1365083">
      <GeneList>
        <Gene Symbol="MAN2B1" FullName="mannosidase alpha class 2B member 1" GeneID="4125" HGNC_ID="HGNC:6826" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12646512" stop="12666742" display_start="12646512" display_stop="12666742" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="12757321" stop="12777590" display_start="12757321" display_stop="12777590" Strand="-" />
          </Location>
          <OMIM>609458</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000528.4(MAN2B1):c.161_162del (p.Thr54fs)</Name>
      <CanonicalSPDI>NC_000019.10:12665802:TGT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19p13.13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12665803" stop="12665804" display_start="12665803" display_stop="12665804" variantLength="2" positionVCF="12665802" referenceAlleleVCF="ATG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="12776617" stop="12776618" display_start="12776617" display_stop="12776618" variantLength="2" positionVCF="12776616" referenceAlleleVCF="ATG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>T54fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.12665804_12665805del" Assembly="GRCh38">
            <Expression>NC_000019.10:g.12665804_12665805del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.12776618_12776619del" Assembly="GRCh37">
            <Expression>NC_000019.9:g.12776618_12776619del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008318.1" sequenceAccession="NG_008318" sequenceVersion="1" change="g.5974_5975del">
            <Expression>NG_008318.1:g.5974_5975del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_015814.1" sequenceAccession="NG_015814" sequenceVersion="1" change="g.4001_4002del">
            <Expression>NG_015814.1:g.4001_4002del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000528.4" sequenceAccession="NM_000528" sequenceVersion="4" change="c.161_162del" MANESelect="true">
            <Expression>NM_000528.4:c.161_162del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000519.2" sequenceAccession="NP_000519" sequenceVersion="2" change="p.Thr54fs">
            <Expression>NP_000519.2:p.Thr54fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001173498.2" sequenceAccession="NM_001173498" sequenceVersion="2" change="c.161_162del">
            <Expression>NM_001173498.2:c.161_162del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001166969.1" sequenceAccession="NP_001166969" sequenceVersion="1" change="p.Thr54fs">
            <Expression>NP_001166969.1:p.Thr54fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2145290975" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000528.4(MAN2B1):c.161_162del (p.Thr54fs) AND Deficiency of alpha-mannosidase" Accession="RCV001907827" Version="3">
        <ClassifiedConditionList TraitSetID="428">
          <ClassifiedCondition DB="MedGen" ID="C0024748">Deficiency of alpha-mannosidase</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-08-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-08-02" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22161967</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9915946</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="428" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2728" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Alpha-Mannosidosis</ElementValue>
                <XRef ID="NBK1396" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lysosomal alpha-D-mannosidase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Alpha mannosidase B deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mannosidosis, alpha B lysosomal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Deficiency of alpha-mannosidase</ElementValue>
                <XRef ID="Alpha-Mannosidosis+Type+1/332" DB="Genetic Alliance" />
                <XRef ID="124466001" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MANSA</ElementValue>
                <XRef Type="MIM" ID="248500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Alpha-mannosidosis encompasses a continuum of clinical findings from mild to severe. Three major clinical subtypes have been suggested: A mild form recognized after age ten years with absence of skeletal abnormalities, myopathy, and slow progression (type 1). A moderate form recognized before age ten years with presence of skeletal abnormalities, myopathy, and slow progression (type 2). A severe form manifested as prenatal loss or early death from progressive central nervous system involvement or infection (type 3). Individuals with a milder phenotype have mild-to-moderate intellectual disability, impaired hearing, characteristic coarse features, clinical or radiographic skeletal abnormalities, immunodeficiency, and primary central nervous system disease â€“ mainly cerebellar involvement causing ataxia. Periods of psychiatric symptoms are common. Associated medical problems can include corneal opacities, hepatosplenomegaly, aseptic destructive arthritis, and metabolic myopathy. Alpha-mannosidosis is insidiously progressive; some individuals may live into the sixth decade.</Attribute>
                <XRef ID="NBK1396" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6968" />
                <XRef ID="6968" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301570</ID>
                <ID Source="BookShelf">NBK1396</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="PubMed">21368911</ID>
              </Citation>
              <XRef ID="61" DB="Orphanet" />
              <XRef ID="C0024748" DB="MedGen" />
              <XRef ID="MONDO:0009561" DB="MONDO" />
              <XRef Type="MIM" ID="248500" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4154769" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="14409921|MedGen:C0024748" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002133583" DateUpdated="2024-02-28" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9915946</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22161967</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Thr54Metfs*19) in the MAN2B1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MAN2B1 are known to be pathogenic (PMID: 9915946, 22161967). This variant is not present in population databases (ExAC no frequency). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with MAN2B1-related conditions.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MAN2B1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.12776617_12776618del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0024748" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4154769" TraitType="Disease" MappingType="XRef" MappingValue="C0024748" MappingRef="MedGen">
        <MedGen CUI="C0024748" Name="Deficiency of alpha-mannosidase" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

